AS
Aayush Srisrimal
About Aayush Srisrimal
Data last updated:
Aayush Srisrimal is a Director at Medi Sales Agencies Private Limited (since 2019), Designated Partner at Maxx Farmacia (India) Llp (since 2018) and Director at Milam Sales Enterprises Private Limited (since 2019), and holds 6 more current directorships. The companies operate in Pharma, Trading and Food And Beverages. The 3 current companies with reported revenue have a combined latest revenue of ₹240 Cr; the largest is Medi Sales Agencies Private Limited at ₹168 Cr (FY 2025). Earlier, Aayush Srisrimal was a Director at Ethico Pharma Private Limited (2015–2019) and Director at Vsk Pharma Private Limited (2015–2022) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Jul 2019 | 2013 | ₹168 Cr (FY 2025) | Active | |
| Designated Partner | 22 May 2018 | 2014 | ₹52.10 Cr (FY 2020) | Active | |
| Director | 10 Jul 2019 | 1994 | ₹19.90 Cr (FY 2024) | Active | |
| Director | 28 Jul 2026 | 2026 | Active | ||
| Partner | 03 Dec 2025 | 2025 | Active | ||
| Designated Partner | 26 Jul 2025 | 2025 | Active | ||
| Director | 23 Sep 2024 | 2024 | Active | ||
| Designated Partner | 06 Nov 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Feb 2015 | 2009 | ₹2,303 (FY 2025) | Active | |
| Director | 26 Feb 2015 | 2008 | ₹7.9 Lakh (FY 2024) | Active | |
| Additional Director | 18 Aug 2017 | 2009 | ₹7.11 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aayush Srisrimal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aayush Srisrimal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aayush Srisrimal
Aayush Srisrimal currently holds 9 directorships: Medi Sales Agencies Private Limited (Director, since 10 Jul 2019, revenue ₹168 Cr (FY 2025)); Maxx Farmacia (India) Llp (Designated Partner, since 22 May 2018, revenue ₹52.10 Cr (FY 2020)); Milam Sales Enterprises Private Limited (Director, since 10 Jul 2019, revenue ₹19.90 Cr (FY 2024)); Iwamet India Private Limited (Director, since 28 Jul 2026); Paraj Realty Llp (Partner, since 03 Dec 2025); and 4 more.
Aayush Srisrimal was first appointed on 26 Feb 2015 as Director at Ethico Pharma Private Limited. The most recent appointment on record is 28 Jul 2026 at Iwamet India Private Limited.
The 3 current companies of Aayush Srisrimal that report revenue have a combined latest revenue of ₹240 Cr: Medi Sales Agencies Private Limited ₹168 Cr (FY 2025); Maxx Farmacia (India) Llp ₹52.10 Cr (FY 2020); Milam Sales Enterprises Private Limited ₹19.90 Cr (FY 2024).
Aayush Srisrimal held 3 earlier board appointments: Ethico Pharma Private Limited (Director, 26 Feb 2015 to 27 Jul 2019); Vsk Pharma Private Limited (Director, 26 Feb 2015 to 26 Apr 2022); Promenade Lifecare Private Limited (Additional Director, 18 Aug 2017 to 27 Aug 2020).
The current boards of Aayush Srisrimal's companies include Ajit Prasad (Medi Sales Agencies Private Limited), Asmitha Srisrimal (Medi Sales Agencies Private Limited), Esha Srisrimal (Medi Sales Agencies Private Limited), Namitha Srisrimal (Medi Sales Agencies Private Limited), Narendra Kumar Srisrimal (Medi Sales Agencies Private Limited), Ayushi Srisrimal (Maxx Farmacia (India) Llp), among others.